GHRP-2 (Growth Hormone Releasing Peptide 2) is a synthetic hexapeptide that activates the ghrelin receptor to stimulate GH release from the pituitary. It's one of the oldest and most extensively studied GHRPs, with a more potent GH pulse than Ipamorelin but a less clean side effect profile — including meaningful cortisol and prolactin elevation that Ipamorelin avoids. Understanding these trade-offs is essential for choosing the right GHRP for any given research protocol.
Research context only. The peptides and compounds discussed on WolveStack are research chemicals not approved for human use by the FDA. Nothing on this page constitutes medical advice. Consult a qualified healthcare professional before use.
GHRP-2 is used to stimulate growth hormone release from the pituitary, primarily for body composition enhancement (increased lean mass, fat loss), recovery, and anti-aging applications. It's also used medically as a diagnostic tool for GH axis testing. Its stronger GH pulse amplitude compared to Ipamorelin makes it preferred in some research protocols despite its less clean side effect profile.
How Does GHRP-2 Work?
GHRP-2, like Ipamorelin, activates the ghrelin receptor (GHSR-1a) in the pituitary. The binding to GHSR-1a triggers pulsatile GH release — the same mechanism as Ipamorelin. The key difference is receptor selectivity. GHRP-2 is less selective than Ipamorelin, producing off-target stimulation of corticotroph cells (elevating cortisol and ACTH) and lactotroph cells (elevating prolactin) alongside GH release.
This reduced selectivity has two consequences: GHRP-2 can produce a slightly larger GH pulse than Ipamorelin in some research subjects (because the cortisol/ACTH co-stimulation adds to the overall stress response that includes GH), but it also produces the cortisol and prolactin elevation that make longer-term use more complicated. Elevated cortisol is catabolic — counteracting some of the benefits of GH elevation for body composition. Elevated prolactin can cause mood effects and libido suppression.
Despite these drawbacks, GHRP-2 remains widely used, particularly in research contexts where maximum GH pulse amplitude is the goal rather than clean long-term optimisation.
Research Evidence
GHRP-2 has been studied since the early 1990s and has more published human data than most research peptides — partly because it was investigated as a diagnostic tool for assessing GH axis function. A single GHRP-2 injection reliably stimulates GH release, making it useful for provocative testing in suspected GH deficiency.
Body composition research with GHRP-2 shows effects consistent with GH elevation: increased lean mass, reduced fat mass, improved recovery. Clinical research also confirmed the cortisol and prolactin elevation issue at standard doses.
The combination of GHRP-2 + GHRH (either endogenous stimulation or exogenous GHRH analogs like CJC-1295) produces the largest GH pulses achievable with secretagogue peptides — larger than either GHRP or GHRH analog alone. This synergistic combination is why many research protocols pair a GHRP with a GHRH analog.
What Is the Recommended GHRP-2 Dosage?
| Protocol | Dose | Route | Timing | Notes |
|---|---|---|---|---|
| Standard | 100–200 mcg | SubQ | Fasted, 3x daily | Standard research dose |
| Diagnostic GH test | 1 mcg/kg body weight | IV or SubQ | Single dose | Medical provocative test |
| Combined with CJC-1295 | 100 mcg each | SubQ | Same injection, fasted | Synergistic GH pulse |
| High pulse (maximum GH) | 200–300 mcg | SubQ | Fasted | More side effects at this range |
What Are the Side Effects of GHRP-2?
**Cortisol elevation:** GHRP-2's most clinically significant drawback. Cortisol is elevated meaningfully with each injection — more so than Ipamorelin. For short-term or intermittent use this is manageable, but for daily long-term protocols the chronic cortisol exposure may offset GH benefits for body composition.
**Prolactin elevation:** Mild prolactin increase with GHRP-2 use. At research doses this rarely produces clinically significant effects, but can contribute to mild libido suppression or mood changes in sensitive individuals. Monitoring prolactin levels with long-term use is advisable.
**Intense hunger:** GHRP-2 activates ghrelin receptors — ghrelin is a potent appetite stimulant. Many users report significant hunger within 30 minutes of injection. More pronounced than with Ipamorelin. This can be advantageous for those trying to increase caloric intake and problematic for those managing weight.
**Water retention:** Standard for all GH secretagogues. Generally resolves after adaptation phase.
**Ipamorelin comparison:** For protocols focused on clean long-term GH optimisation, Ipamorelin is the preferred choice. GHRP-2 is better suited for short-term maximum GH stimulation or research protocols where the cortisol/prolactin effects are acceptable trade-offs for higher peak GH.
Research-Grade Sourcing
WolveStack partners with Ascension Peptides for independently third-party tested research compounds with published COAs. The links below go directly to the relevant products.
For research purposes only. Affiliate disclosure: WolveStack earns a commission on qualifying purchases at no additional cost to you.
Also Available at Apollo Peptide Sciences
Apollo Peptide Sciences carries independently tested research-grade compounds. Products ship from the USA with published purity certificates.
For research purposes only. Affiliate disclosure: WolveStack earns a commission on qualifying purchases at no additional cost to you.
Frequently Asked Questions
GHRP-2 is used to stimulate growth hormone release from the pituitary, primarily for body composition enhancement (increased lean mass, fat loss), recovery, and anti-aging applications. It's also used medically as a diagnostic tool for GH axis testing. Its stronger GH pulse amplitude compared to Ipamorelin makes it preferred in some research protocols despite its less clean side effect profile.
For long-term GH optimisation with minimal side effects, Ipamorelin is the superior choice — it produces clean GH pulses without meaningful cortisol or prolactin elevation. GHRP-2 produces a larger GH pulse but elevates cortisol and prolactin as off-target effects. GHRP-2 is preferred when maximum GH pulse amplitude is the priority over long-term use.
No — GHRP-2 should be injected fasted. Elevated blood glucose and free fatty acids suppress GH release. The pre-sleep injection should follow 2+ hours of fasting for maximum effect.
GHRP-2's prolactin elevation is generally mild and unlikely to cause gynecomastia at research doses. However, prolactin elevation combined with other aromatizable compounds (anabolic steroids) could theoretically increase risk. Monitoring prolactin levels with long-term GHRP-2 use is advisable for individuals concerned about this.
For clean long-term use: Ipamorelin. For maximum GH pulse: GHRP-2. For hunger stimulation alongside GH release: GHRP-6. Each has different applications. Most modern protocols have shifted toward Ipamorelin for its selectivity, reserving GHRP-2 for specific applications where its stronger pulse is needed.
Standard protocols use 2–3 injections daily to take advantage of multiple GH pulse windows throughout the day. Each injection should be fasted. The most important injection is pre-sleep to amplify the natural nocturnal GH pulse. Many protocols use pre-workout + pre-sleep as a 2x daily minimum.